Research & Education

The new IASLC/ATS/ERS Lung Adenocarcinoma Classification - Module 1: Introduction

In 2011, the Journal for Thoracic Oncology published the “International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma,” issued by a multidisciplinary team of lung cancer specialists.

The new IASLC/ATS/ERS Lung Adenocarcinoma Classification - Module 2: Implications

In 2011, the Journal for Thoracic Oncology published the “International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma,” issued by a multidisciplinary team of lung cancer specialists.

The New IASLC/ATS/ERS Lung Adenocarcinoma Classification - Module 3: Highlights for the Pathologists

In 2011, the Journal for Thoracic Oncology published the “International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma,” issued by a multidisciplinary team of lung cancer specialists.

The New IASLC/ATS/ERS Lung Adenocarcinoma Classification - Module 4: Highlights for the Radiologists

In 2011, the Journal for Thoracic Oncology published the “International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma,” issued by a multidisciplinary team of lung cancer specialists.

The New IASLC/ATS/ERS Lung Adenocarcinoma Classification - Module 5: Case Studies for the Practicing Clinician

In 2011, the Journal for Thoracic Oncology published the “International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma,” issued by a multidisciplinary team of lung cancer specialists.

New Developments in Non-small Cell Lung Cancer

This webinar addresses the new lung cancer staging system and genetic testing for optimal therapy of non-small cell lung cancer. Dr. Peter Goldstraw discusses the new lung cancer staging system. Dr. Paul Bunn covers genetic testing for optimal therapy. Dr. Harvey Pass and Dr. Paul Bunn offer case studies using the new staging system.

Considerations for Practice: Women and Lung Cancer

This webinar features an introduction by Dr. Joan Schiller, who will discuss the incidence, epidemiology and etiology of lung cancer in women.

Pages